Actively embracing the evolution of CMR Institute

Through a far-reaching strategic plan, the well-respected CMR Institute Board of Directors is committed to actively support the implementation of new technology, the continuing development of comprehensive healthcare curriculum, and reaching out to new healthcare market segments.

Board of Directors:

J. Lyle Bootman , Ph.D., Dean and Professor, College of Pharmacy, Arizona Health Science Center, University of Arizona (Chairman of the Strategic Advisory Board)

James E. Dutton , CMR, President, CMR Institute

Cherie G. Hicks , CPA, COO, CMR Institute

Philip P. Gerbino , PharmD, President, University of the Sciences in Philadelphia
(Chairman of the Audit Committee)

Jeff Mackie, Ph.D., Ret. Ambassador, GlaxoSmithKline Pharmaceuticals (Chairman of the Board)

Patton B. Saul , MD, Medical Director & Director of Gynecologic Oncology, Lewis Gale Cancer Center (Vice Chairman of the Board)

Donald Stark , Director Emeritus, Director Antex Biologics, and Director Amherst Fiberoptics (Ret. President and CEO, Nova Pharmaceutical Corp, Ret. President of Sterling Drug, Inc.; Ret. President of Sandoz Pharmaceuticals)

Board members may click here to login to the Board Member Site.

Home | Contact Us | Legal | Privacy | Links | Site Index

© Certified Medical Representatives Institute, Inc. All Rights Reserved.
CMR, CMRI, and CPM are registered trademarks of Certified Medical Representatives Institute, Inc.